Susanne B. Gjedde

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

Lars Bastholt, M. Dalmark, Susanne B. Gjedde et al. · Journal of Clinical Oncology · 1996 · 173 citations

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

J Pedersen-Bjergaard, Torben Sigsgaard, Dorte Nielsen et al. · Journal of Clinical Oncology · 1992 · 130 citations

Prevalence and Prognostic Significance of Infection with TT Virus in Patients Infected with Human Immunodeficiency Virus

J K Christensen, Jesper Eugen‐Olsen, Marie Sørensen et al. · The Journal of Infectious Diseases · 2000 · 100 citations · Full text

Primary Immunodeficiency, Viral Persistence, Human Retrovirus +15

A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement

Preben Jakobsen, Lars Bastholt, M. Dalmark et al. · Cancer Chemotherapy and Pharmacology · 1991 · 60 citations

Single Blood-sample Measurement, Breast Oncology, Oncology +10

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer

Preben Jakobsen, Eva Steiness, Lars Bastholt et al. · Cancer Chemotherapy and Pharmacology · 1991 · 36 citations

Metastatic Breast Cancer, Oncology, Different Dose Levels +8